(192) used an adenoviral vector (Ad-SPINK7) as a biological treatment tool and found that Ad-SPINK7 can inhibit the invasion and adhesion of HCC cells at a low titer and change the expression of NF-κB, MMP2 and E-cadherin to reverse the malignant tumor phenotype. Here, CDH1 is linked to hepatocellular carcinoma.